Amy Ontai-Brenning

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Hypoalbuminemia as a Predictive Biomarker of Dyspnea Response to Dexamethasone and Placebo in Patients With Cancer: Secondary Analysis of the ABCD Randomized Clinical Trial.

|Dec 02, 2025
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON): A personalized randomized clinical trial protocol.

David Hui, Min Ji Kim, Saji Thomas

|Oct 20, 2025
Efficacy of fentanyl buccal tablet and morphine for exertional dyspnoea in patients with cancer: a double-blind, placebo-controlled, randomised clinical trial.

David Hui, Soraira Pacheco, Linh Nguyen

|Sep 23, 2025
Integration of Remote Monitoring Into Palliative Care for Patients With Advanced Cancer Undergoing Phase I Therapies: A Randomized Clinical Trial.

David Hui, Ishwaria M Subbiah, David Hong

|Nov 16, 2023
Gut microbes modulate (p)ppGpp during a time-restricted feeding regimen.

Amy Ontai-Brenning, Randy Hamchand, Jason M Crawford

Pageof 1

Frequent Collaborators

4 joint publications

David Hui

2 joint publications

Sanjay Shete

2 joint publications

Eduardo Bruera

1 joint publications

Ishwaria M Subbiah